AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 144 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,242,846 | -7.8% | 50,216 | +5.5% | 0.00% | 0.0% |
Q2 2023 | $1,348,145 | +24.8% | 47,604 | +1.3% | 0.00% | 0.0% |
Q1 2023 | $1,079,912 | -29.3% | 47,014 | -14.8% | 0.00% | 0.0% |
Q4 2022 | $1,526,875 | -2.8% | 55,153 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $1,570,531 | +26.7% | 55,196 | -0.7% | 0.00% | 0.0% |
Q2 2022 | $1,239,285 | -22.8% | 55,586 | +1.3% | 0.00% | 0.0% |
Q1 2022 | $1,605,053 | +71.5% | 54,863 | +94.8% | 0.00% | 0.0% |
Q4 2021 | $936,000 | -33.9% | 28,161 | -8.2% | 0.00% | 0.0% |
Q3 2021 | $1,416,000 | -26.2% | 30,686 | -11.9% | 0.00% | -50.0% |
Q2 2021 | $1,919,000 | +1261.0% | 34,830 | +1972.0% | 0.00% | – |
Q2 2018 | $141,000 | +3.7% | 1,681 | +0.8% | 0.00% | – |
Q1 2018 | $136,000 | +60.0% | 1,668 | +12.5% | 0.00% | – |
Q4 2017 | $85,000 | -13.3% | 1,483 | +1.2% | 0.00% | – |
Q3 2017 | $98,000 | +66.1% | 1,465 | +28.4% | 0.00% | – |
Q2 2017 | $59,000 | -6.3% | 1,141 | +6.5% | 0.00% | – |
Q1 2017 | $63,000 | +40.0% | 1,071 | 0.0% | 0.00% | – |
Q4 2016 | $45,000 | -19.6% | 1,071 | +1.6% | 0.00% | – |
Q3 2016 | $56,000 | +27.3% | 1,054 | -0.6% | 0.00% | – |
Q2 2016 | $44,000 | +10.0% | 1,060 | +0.6% | 0.00% | – |
Q1 2016 | $40,000 | -41.2% | 1,054 | 0.0% | 0.00% | – |
Q4 2015 | $68,000 | -8.1% | 1,054 | 0.0% | 0.00% | – |
Q3 2015 | $74,000 | -37.3% | 1,054 | -0.9% | 0.00% | – |
Q2 2015 | $118,000 | -87.5% | 1,064 | -89.4% | 0.00% | -100.0% |
Q1 2015 | $945,000 | -9.7% | 10,021 | +7.2% | 0.00% | -50.0% |
Q4 2014 | $1,047,000 | +82.7% | 9,350 | +0.1% | 0.00% | +100.0% |
Q3 2014 | $573,000 | +35.8% | 9,345 | +1.6% | 0.00% | 0.0% |
Q2 2014 | $422,000 | +79.6% | 9,195 | +53.0% | 0.00% | – |
Q1 2014 | $235,000 | +80.8% | 6,011 | +10.3% | 0.00% | – |
Q4 2013 | $130,000 | +2500.0% | 5,449 | +2861.4% | 0.00% | – |
Q3 2013 | $5,000 | – | 184 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |